Your browser doesn't support javascript.
loading
Serum Proteomic Profiles of Patients with Chronic Recurrent Multifocal Osteomyelitis.
Kawada, Jun-Ichi; Yamaguchi, Makoto; Haruta, Kazunori; Fukuda, Yuto; Iwata, Ken-Ichi; Suzuki, Takako; Torii, Yuka.
Afiliação
  • Kawada JI; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Yamaguchi M; Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Haruta K; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Fukuda Y; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Iwata KI; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Suzuki T; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Torii Y; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Article em En | MEDLINE | ID: mdl-38775453
ABSTRACT

OBJECTIVES:

Chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory disease characterized by sterile bone inflammation; however, its pathophysiology is poorly understood. Thus, this study aimed to characterize the serum proteomic profiles of patients with CRMO to better understand the molecular mechanisms underpinning CRMO pathogenesis.

METHODS:

Proteomic profiling of the sera collected from 11 patients with CRMO (five patients were in active phase, six were in inactive phase) was conducted using liquid chromatography-mass spectrometry. Sera from four children without inflammatory diseases were used as controls. Pathway analysis was performed to identify the upregulated and downregulated proteins in patients with active CRMO.

RESULTS:

Compared with the control group, 19 and 41 proteins were upregulated and downregulated, respectively, in patients with active CRMO. Pathway and process enrichment analyses revealed that axon guidance was the most enriched category of upregulated proteins in patients with active CRMO, followed by neutrophil degranulation and mitogen-activated protein kinase cascade regulation. In comparison to patients with inactive CRMO, 36 proteins, including 11 keratin proteins, were upregulated and highly enriched in the intermediate filament organization category. Rho GTPase pathway-related proteins were downregulated in ibuprofen-treated patients.

CONCLUSION:

Proteomic analysis identified upregulated proteins in the sera of patients with acute CRMO. These proteins can be used as biomarkers for disease diagnosis and activity. Furthermore, we anticipate that this study will contribute to a deeper understanding of the pathophysiology of CRMO, which, in turn, will contribute to the discovery of potential novel therapeutic targets.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article